Funding

• 3 x DZIF


• EU (ERC Advanced Grant)


• EU (European HIV Vaccine Alliance)


• 5 x FHH (LFF)


• Hector Stiftung


• DFG:

  1. Innate immune cells in the pathogenesis of PSC
  2. Metabolic determinants of HIV-1-associated pathogenesis
  3. Impact of KIR/HLA-C interactions on the anti-HIV activity of NK cells
  4. SFB 841: HCV infection: Mechanisms of NK-cell-mediated control
  5. SFB 841 (increase): Mechanisms underlying and consequences of hepatic and intestinal manifestations of COVID-19